Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Aug 07, 2012

Mylan Launches Generic Version of Singulair® Tablets and Singulair® Chewable Tablets

Aug 06, 2012

Mylan Launches Generic Version of Amidate® Injection

Aug 06, 2012

Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS

Aug 02, 2012

Mylan Applauds Study Highlighting $1 Trillion in Savings for U.S. Health Care System Due to Generic Drugs Over Past Decade

Aug 02, 2012

Mylan Signs Agreement with Gilead to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine

Jul 31, 2012

Mylan Specialty L.P. Partners with the Pittsburgh Pirates to Sponsor PNC Park's First Allergy Awareness Night

Jul 27, 2012

Mylan Launches Generic Version of Sporanox® Capsules

Jul 26, 2012

Mylan Reports Second Quarter 2012 Adjusted Diluted EPS of $0.60, a 15% Increase Over Prior Year Quarter

Jul 17, 2012

Mylan Announces Settlement Agreement in Litigation Relating to its Generic Silenor®

Jul 10, 2012

Mylan Schedules Second Quarter 2012 Financial Results Conference Call and Live Webcast

Pagination

First page
Previous page
…
Page 58
Page 59
Page 60
Page 61
Current page 62
Page 63
Page 64
Page 65
Page 66
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.